Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,773 JPY | +22.00% | +51.61% | +38.03% |
2023 | I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2022 | Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 1,890.00 | 2,083.00 | 2,056.00 |
Spread/Res. | +46.72% | +33.13% | +34.87% |
Spread/Supp. | +52.78% | +59.64% | +66.85% |
Support | 1,815.00 | 1,737.00 | 1,662.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 2372 Stock
- Charts I'rom Group Co., Ltd.